Global Influenza Vaccine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Influenza Vaccine market size will reach 10,522 Million USD in 2025 and is projected to reach 15,378 Million USD by 2032, with a CAGR of 5.57% (2025-2032). Notably, the China Influenza Vaccine market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An influenza vaccine, commonly known as the flu shot, is a preventive medical treatment designed to protect individuals from infection by the influenza virus. Influenza vaccines contain inactivated or weakened strains of the influenza virus or its components, stimulating the immune system to develop antibodies. These antibodies can recognize and neutralize the virus when the body encounters it, reducing the severity of illness and the risk of complications if exposed to the flu. Influenza vaccines are administered annually, typically before the flu season, and are especially recommended for individuals at higher risk of complications, such as the elderly, young children, pregnant women, and people with certain medical conditions. Mass vaccination programs have contributed to the reduction of flu-related illnesses and hospitalizations, making the influenza vaccine a crucial tool in public health efforts to prevent the spread of the flu.
The major global suppliers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Vaccine Include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Influenza Vaccine Product Segment Include:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Influenza Vaccine Product Application Include:
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis
Chapter 3: Global Influenza Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Vaccine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Vaccine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Vaccine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Vaccine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Influenza Vaccine market size will reach 10,522 Million USD in 2025 and is projected to reach 15,378 Million USD by 2032, with a CAGR of 5.57% (2025-2032). Notably, the China Influenza Vaccine market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An influenza vaccine, commonly known as the flu shot, is a preventive medical treatment designed to protect individuals from infection by the influenza virus. Influenza vaccines contain inactivated or weakened strains of the influenza virus or its components, stimulating the immune system to develop antibodies. These antibodies can recognize and neutralize the virus when the body encounters it, reducing the severity of illness and the risk of complications if exposed to the flu. Influenza vaccines are administered annually, typically before the flu season, and are especially recommended for individuals at higher risk of complications, such as the elderly, young children, pregnant women, and people with certain medical conditions. Mass vaccination programs have contributed to the reduction of flu-related illnesses and hospitalizations, making the influenza vaccine a crucial tool in public health efforts to prevent the spread of the flu.
The major global suppliers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Vaccine Include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Influenza Vaccine Product Segment Include:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Influenza Vaccine Product Application Include:
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis
Chapter 3: Global Influenza Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Vaccine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Vaccine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Vaccine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Vaccine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Influenza Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Influenza Vaccine Product by Type
- 1.2.1 Trivalent Influenza Vaccine
- 1.2.2 Quadrivalent Influenza Vaccine
- 1.3 Influenza Vaccine Product by Application
- 1.3.1 6 Months to 3 Years
- 1.3.2 ＞ 3 Years
- 1.4 Global Influenza Vaccine Market Size Analysis (2020-2032)
- 1.5 Influenza Vaccine Market Development Status and Trends
- 1.5.1 Influenza Vaccine Industry Development Status Analysis
- 1.5.2 Influenza Vaccine Industry Development Trends Analysis
- 2 Influenza Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Influenza Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Influenza Vaccine Market Analysis by Country
- 4.1 Global Influenza Vaccine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Influenza Vaccine Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Influenza Vaccine Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.5 China Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.6 France Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.14 India Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Influenza Vaccine Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Influenza Vaccine Market Revenue by Key Suppliers (2021-2025)
- 5.2 Influenza Vaccine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Influenza Vaccine Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Influenza Vaccine Market Analysis by Type
- 6.1 Global Influenza Vaccine Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Influenza Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sanofi
- 7.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sanofi Influenza Vaccine Product Portfolio
- 7.1.3 Sanofi Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CSL
- 7.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CSL Influenza Vaccine Product Portfolio
- 7.2.3 CSL Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 GSK
- 7.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GSK Influenza Vaccine Product Portfolio
- 7.3.3 GSK Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Viatris
- 7.4.1 Viatris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Viatris Influenza Vaccine Product Portfolio
- 7.4.3 Viatris Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 AstraZeneca Influenza Vaccine Product Portfolio
- 7.5.3 AstraZeneca Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Hualan Bio
- 7.6.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hualan Bio Influenza Vaccine Product Portfolio
- 7.6.3 Hualan Bio Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Changchun Institute of Biological
- 7.7.1 Changchun Institute of Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolio
- 7.7.3 Changchun Institute of Biological Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Sinovac
- 7.8.1 Sinovac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Sinovac Influenza Vaccine Product Portfolio
- 7.8.3 Sinovac Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 BCHT
- 7.9.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 BCHT Influenza Vaccine Product Portfolio
- 7.9.3 BCHT Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Jiangsu GDK
- 7.10.1 Jiangsu GDK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Jiangsu GDK Influenza Vaccine Product Portfolio
- 7.10.3 Jiangsu GDK Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 KM Biologics
- 7.11.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 KM Biologics Influenza Vaccine Product Portfolio
- 7.11.3 KM Biologics Influenza Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Influenza Vaccine Industry Chain Analysis
- 8.2 Influenza Vaccine Product Downstream Application Analysis
- 8.2.1 Global Influenza Vaccine Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Influenza Vaccine Revenue and Forecast by Application (2020-2032)
- 8.3 Influenza Vaccine Typical Downstream Customers
- 8.4 Influenza Vaccine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
